242 related articles for article (PubMed ID: 32062931)
1. [How to adjust confounders in studies on observational comparative effectiveness: (3) approaches on sensitivity analysis for confounder adjustment].
Huang LL; Zhao Y; Wei YY; Chen F
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Dec; 40(12):1645-1649. PubMed ID: 32062931
[TBL] [Abstract][Full Text] [Related]
2. [Confounder adjustment in observational comparative effectiveness researches: (2) statistical adjustment approaches for unmeasured confounders].
Huang LL; Wei YY; Chen F
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1450-1455. PubMed ID: 31838820
[TBL] [Abstract][Full Text] [Related]
3. Adjustment for unmeasured confounding through informative priors for the confounder-outcome relation.
Groenwold RHH; Shofty I; Miočević M; van Smeden M; Klugkist I
BMC Med Res Methodol; 2018 Dec; 18(1):174. PubMed ID: 30577773
[TBL] [Abstract][Full Text] [Related]
4. [Confounder adjustment in observational comparative effectiveness researches: (1) statistical adjustment approaches for measured confounder].
Huang LL; Wei YY; Chen F
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Oct; 40(10):1304-1309. PubMed ID: 31658535
[TBL] [Abstract][Full Text] [Related]
5. A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases.
Benasseur I; Talbot D; Durand M; Holbrook A; Matteau A; Potter BJ; Renoux C; Schnitzer ME; Tarride JÉ; Guertin JR
Pharmacoepidemiol Drug Saf; 2022 Apr; 31(4):424-433. PubMed ID: 34953160
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the impact of unmeasured confounding with internal validation data: an example cost evaluation in type 2 diabetes.
Faries D; Peng X; Pawaskar M; Price K; Stamey JD; Seaman JW
Value Health; 2013; 16(2):259-66. PubMed ID: 23538177
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity analysis for the effects of multiple unmeasured confounders.
Groenwold RH; Sterne JA; Lawlor DA; Moons KG; Hoes AW; Tilling K
Ann Epidemiol; 2016 Sep; 26(9):605-11. PubMed ID: 27576907
[TBL] [Abstract][Full Text] [Related]
8. Flexible propensity score estimation strategies for clustered data in observational studies.
Chang TH; Nguyen TQ; Lee Y; Jackson JW; Stuart EA
Stat Med; 2022 Nov; 41(25):5016-5032. PubMed ID: 36263918
[TBL] [Abstract][Full Text] [Related]
9. Bayesian sensitivity analysis for unmeasured confounding in causal mediation analysis.
McCandless LC; Somers JM
Stat Methods Med Res; 2019 Feb; 28(2):515-531. PubMed ID: 28882092
[TBL] [Abstract][Full Text] [Related]
10. "A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis".
Zhang X; Faries DE; Boytsov N; Stamey JD; Seaman JW
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):982-92. PubMed ID: 27396534
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity analysis of treatment effect to unmeasured confounding in observational studies with survival and competing risks outcomes.
Huang R; Xu R; Dulai PS
Stat Med; 2020 Oct; 39(24):3397-3411. PubMed ID: 32677758
[TBL] [Abstract][Full Text] [Related]
12. Adjustment for time-dependent unmeasured confounders in marginal structural Cox models using validation sample data.
Burne RM; Abrahamowicz M
Stat Methods Med Res; 2019 Feb; 28(2):357-371. PubMed ID: 28835193
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity Analysis Without Assumptions.
Ding P; VanderWeele TJ
Epidemiology; 2016 May; 27(3):368-77. PubMed ID: 26841057
[TBL] [Abstract][Full Text] [Related]
14. Magnitude and direction of missing confounders had different consequences on treatment effect estimation in propensity score analysis.
Nguyen TL; Collins GS; Spence J; Fontaine C; Daurès JP; Devereaux PJ; Landais P; Le Manach Y
J Clin Epidemiol; 2017 Jul; 87():87-97. PubMed ID: 28412467
[TBL] [Abstract][Full Text] [Related]
15. Bayesian sensitivity analysis for unmeasured confounding in observational studies.
McCandless LC; Gustafson P; Levy A
Stat Med; 2007 May; 26(11):2331-47. PubMed ID: 16998821
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity analyses of unmeasured and partially-measured confounders using multiple imputation in a vaccine safety study.
Xu S; Clarke CL; Newcomer SR; Daley MF; Glanz JM
Pharmacoepidemiol Drug Saf; 2021 Sep; 30(9):1200-1213. PubMed ID: 33988275
[TBL] [Abstract][Full Text] [Related]
17. Monte Carlo sensitivity analysis for unmeasured confounding in dynamic treatment regimes.
Rose EJ; Moodie EEM; Shortreed SM
Biom J; 2023 Jun; 65(5):e2100359. PubMed ID: 37017498
[TBL] [Abstract][Full Text] [Related]
18. A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding.
McCandless LC; Gustafson P; Levy AR
J Clin Epidemiol; 2008 Mar; 61(3):247-55. PubMed ID: 18226747
[TBL] [Abstract][Full Text] [Related]
19. How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies.
Barrowman MA; Peek N; Lambie M; Martin GP; Sperrin M
BMC Med Res Methodol; 2019 Jul; 19(1):166. PubMed ID: 31366331
[TBL] [Abstract][Full Text] [Related]
20. [Sensitivity analysis method for unmeasured confounding interference in observational study].
Wang DH; You DF; Huang LL; Zhao Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1470-1475. PubMed ID: 31838823
[No Abstract] [Full Text] [Related]
[Next] [New Search]
